Commentary: Advertising adversities
| Autor: | Christo Gg, R Balasubramaniam |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Drug Industry
Financial stability Drug advertising business.industry General Engineering India Advertising Legislation General Medicine Advertising revenue Food and drug administration Statutory law General Earth and Planetary Sciences Medicine Periodicals as Topic Medical prescription business Research Article General Environmental Science Pharmaceutical industry |
| Zdroj: | BMJ. 315:460-460 |
| ISSN: | 1468-5833 0959-8138 |
| DOI: | 10.1136/bmj.315.7106.460 |
| Popis: | Misleading drug advertising in medical journals has been a thorny issue for over 100 years1 in many countries.2 3 4 In India, dealing with the pharmaceutical industry and its promotional activities presents some distinctive challenges. Firstly, there is no legislation or statutory organisation such as the Food and Drug Administration in the United States that regulates the accuracy of advertisements for prescription drugs. Secondly, there are no effective watchdog groups such as the Pharmaceutical Advertising Advisory Board in Canada3 or the Medical Lobby for Appropriate Marketing in Australia.4 Thirdly, ayurvedic and other non-allopathic medications are widely used and there are few scientific data on these drugs, though they are ubiquitously advertised. Most medical journals run on lean budgets, and advertising revenue in the early years of the Indian edition of the BMJ provided financial stability. It soon became apparent, however, that some advertisements lacked information and scientific accuracy. Several contained excessive or … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|